Stay updated on Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.5.3 to v3.5.4. This represents an administrative version update to the study documentation rather than a substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-05-16T10:17:49.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page revision indicator has been updated from v3.5.2 to v3.5.3, reflecting a site/version update without changing the study details.
    Difference
    0.1%
    Check dated 2026-04-24T22:25:43.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:11:20.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added Small cell lung carcinoma as a topic and added a new 'Genetic and Rare Diseases Information Center' resource under Resources.
    Difference
    0.2%
    Check dated 2026-04-03T06:07:22.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0 (added) and v3.4.3 (removed). This change is limited to page metadata and does not affect the study content or user interactions.
    Difference
    0.1%
    Check dated 2026-03-20T00:20:46.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed; this appears to be a minor site revision with no changes to the study content, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-02-12T03:49:34.000Z thumbnail image

Stay in the know with updates to Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib+Nivolumab in Small Cell Lung Carcinoma Clinical Trial page.